Angiotensin‐converting enzyme inhibitor works as a scar formation inhibitor by down‐regulating Smad and TGF‐β‐activated kinase 1 (TAK1) pathways in mice - Tan, Wei‐Qiang; Fang, Qing‐Qing; Shen, Xiao Z; Giani, Jorge F; Zhao, Tuantuan V; Shi, Peng; Zhang, Li‐Yun; Khan, Zakir; Li, You; Li, Liang; Xu, Ji‐Hua; Bernstein, Ellen A; et al. (British journal of pharmacology, 2018)
Keywords: Angiotensin-Converting Enzyme Inhibitors - pharmacology; Animals; Disease Models, Animal; Male; MAP Kinase Kinase Kinases - antagonists & inhibitors; MAP Kinase Kinase Kinases - deficiency; MAP Kinase Kinase Kinases - metabolism; Mice; Mice, Knockout; Research Paper; Research Papers; Signal Transduction - drug effects; Smad Proteins - antagonists & inhibitors; Smad Proteins - metabolism